Evaluating patient preferences for discussing advance care planning in oncology
Which Health-care Professional(s) to Talk About Advance Care Planning ? The Point of View of French Patients Followed in the Context of an Oncological Disease.
University Hospital, Grenoble · NCT06376799
This study is trying to find out which healthcare professional cancer patients in France would rather talk to about planning their future care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 240 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Grenoble (other) |
| Locations | 1 site (Grenoble) |
| Trial ID | NCT06376799 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the preferences of French adult patients with oncological diseases regarding which healthcare professional they prefer to discuss advance care planning. Participants will complete a self-questionnaire, available in both electronic and paper formats, to indicate their choices. The study focuses on understanding patient preferences to improve communication and decision-making in advance care planning.
Who should consider this trial
Good fit: Ideal candidates are French-speaking adults currently undergoing treatment for neoplastic diseases or in palliative care.
Not a fit: Patients who do not speak French or are not currently involved in oncological care may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient-centered care by aligning advance care planning discussions with patient preferences.
How similar studies have performed: While there may be studies on advance care planning, this specific focus on patient preferences in an oncological context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria : * Patients with neoplasic disease (under treatment, in exclusive palliative phase, under surveillance or in remission) * French-speaking patients
Where this trial is running
Grenoble
- CHU Grenoble Alpes — Grenoble, France (RECRUITING)
Study contacts
- Study coordinator: Jérémy Lascaux, Master
- Email: lascaux.jeremy@hotmail.fr
- Phone: 0630865262
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Advance Care Planning, Patient Preference, Advance care planning, Patient preference